386 related articles for article (PubMed ID: 17351373)
61. Upregulation of the Na(+)-K(+)-2Cl(-) cotransporter 1 via histone modification in the aortas of angiotensin II-induced hypertensive rats.
Cho HM; Lee DY; Kim HY; Lee HA; Seok YM; Kim IK
Hypertens Res; 2012 Aug; 35(8):819-24. PubMed ID: 22495607
[TBL] [Abstract][Full Text] [Related]
62. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats.
Wang H; Chen AF; Watts SW; Galligan JJ; Fink GD
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H729-36. PubMed ID: 15471983
[TBL] [Abstract][Full Text] [Related]
63. Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats.
Demel SL; Galligan JJ
Hypertension; 2008 Aug; 52(2):322-9. PubMed ID: 18606906
[TBL] [Abstract][Full Text] [Related]
64. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.
Florian JA; Watts SW
Am J Physiol; 1999 Mar; 276(3):H976-83. PubMed ID: 10070082
[TBL] [Abstract][Full Text] [Related]
65. Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats.
Soltis EE; Field FP
Hypertension; 1986 Nov; 8(11):1032-9. PubMed ID: 2429928
[TBL] [Abstract][Full Text] [Related]
66. Increased sensitivity of serotonin on the voltage-dependent K+ channels in mesenteric arterial smooth muscle cells of OLETF rats.
Ko EA; Park WS; Firth AL; Hong DH; Choi SW; Heo HJ; Kim MH; Noh JH; Ko JH; Kim N; Earm YE; Song DK; Han J
Prog Biophys Mol Biol; 2010 Sep; 103(1):88-94. PubMed ID: 20219524
[TBL] [Abstract][Full Text] [Related]
67. Potassium relaxation of vascular smooth muscle from DOCA hypertensive pigs.
Webb RC
Hypertension; 1982; 4(5):609-19. PubMed ID: 6286478
[TBL] [Abstract][Full Text] [Related]
68. Sodium pump activity and norepinephrine responsiveness of femoral arterial smooth muscle from DOCA-salt rats.
Soltis EE; Field FP
Pharmacology; 1987; 34(2-3):104-10. PubMed ID: 3588654
[TBL] [Abstract][Full Text] [Related]
69. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells.
Jung S; Strotmann R; Schultz G; Plant TD
Am J Physiol Cell Physiol; 2002 Feb; 282(2):C347-59. PubMed ID: 11788346
[TBL] [Abstract][Full Text] [Related]
70. Transient receptor potential channels regulate myogenic tone of resistance arteries.
Welsh DG; Morielli AD; Nelson MT; Brayden JE
Circ Res; 2002 Feb; 90(3):248-50. PubMed ID: 11861411
[TBL] [Abstract][Full Text] [Related]
71. Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries.
Schleifenbaum J; Kassmann M; Szijártó IA; Hercule HC; Tano JY; Weinert S; Heidenreich M; Pathan AR; Anistan YM; Alenina N; Rusch NJ; Bader M; Jentsch TJ; Gollasch M
Circ Res; 2014 Jul; 115(2):263-72. PubMed ID: 24838176
[TBL] [Abstract][Full Text] [Related]
72. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.
Atkins KB; Johns D; Watts S; Clinton Webb R; Brosius FC
J Hypertens; 2001 Sep; 19(9):1581-7. PubMed ID: 11564977
[TBL] [Abstract][Full Text] [Related]
73. Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels.
Chen X; Yang D; Ma S; He H; Luo Z; Feng X; Cao T; Ma L; Yan Z; Liu D; Tepel M; Zhu Z
J Cell Mol Med; 2010 Oct; 14(10):2483-94. PubMed ID: 19725917
[TBL] [Abstract][Full Text] [Related]
74. Expression of transient receptor channel proteins in human fundal myometrium in pregnancy.
Ku CY; Babich L; Word RA; Zhong M; Ulloa A; Monga M; Sanborn BM
J Soc Gynecol Investig; 2006 Apr; 13(3):217-25. PubMed ID: 16527499
[TBL] [Abstract][Full Text] [Related]
75. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression.
Liu Y; Ji Z
J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594
[TBL] [Abstract][Full Text] [Related]
76. The serotonin transporter is present and functional in peripheral arterial smooth muscle.
Ni W; Thompson JM; Northcott CA; Lookingland K; Watts SW
J Cardiovasc Pharmacol; 2004 Jun; 43(6):770-81. PubMed ID: 15167270
[TBL] [Abstract][Full Text] [Related]
77. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
Banes AK; Watts SW
BMC Pharmacol; 2003 Sep; 3():12. PubMed ID: 12974983
[TBL] [Abstract][Full Text] [Related]
78. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension.
Martens JR; Gelband CH
Circ Res; 1996 Aug; 79(2):295-301. PubMed ID: 8756007
[TBL] [Abstract][Full Text] [Related]
79. Vascular responsiveness to protein kinase C activators in mineralocorticoid-hypertensive rats.
Turla MB; Webb RC
J Hypertens; 1991 Mar; 9(3):209-15. PubMed ID: 1851783
[TBL] [Abstract][Full Text] [Related]
80. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.
Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR
Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
